• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

UK Epilepsy Market Insights Capsule - 2013

  • ID: 2599189
  • July 2013
  • Region: United Kingdom, Great Britain
  • 25 pages
  • Fore Pharma

The latest research UK Epilepsy Market Insights Capsule, presents epilepsy market competitive landscape and epilepsy drug forecasts in UK.

The research finds market events that characterize the UK epilepsy market. The research includes UK epilepsy market size estimate for 2012 and forecasts for six years to 2018, epilepsy products market share, neurologists’ drug prescribing trends, late stage epilepsy pipeline products, and epilepsy prevalence in UK.

This research will help executive track competitor product sales and market share in UK epilepsy market. It enables informed decision making from R&D to long term marketing strategies. The insights presented in this report can be used for evaluating business opportunities, formulating business development strategies, and product positioning in UK epilepsy market.

Highlights of the Research:
- UK epilepsy market analysis
- Competitive landscape in UK epilepsy market
- UK epilepsy market forecasts to 2018
- Epilepsy product sales forecast to 2018 in UK
- Epilepsy late stage pipeline

Note: Product cover images may vary from those shown

1. Epilepsy: Disease Definition
2. Epilepsy Epidemiology in UK
3. Epilepsy Therapies in UK
4. UK Epilepsy Market Analysis
a. Epilepsy Drug Sales Analysis
b. Prescribing Trends
5. Competitive Landscape in UK Epilepsy market
6. Epilepsy Late Stage Pipeline
7. UK Epilepsy Market Forecast
a. Epilepsy Drug Sales Forecast
b. Future Competitive Landscape
Table 1: Epilepsy Prevalence in UK (2012-2018)
Table 2: Epilepsy Therapies Marketed in UK (2012)
Table 3: Epilepsy Drug Sales in UK (2012)
Table 4: Epilepsy Late Stage Pipeline (2013)
Table 5: UK Epilepsy Market Forecast (2012-2018)
Table 6: Epilepsy Drug Sales Forecast in UK (2012-2018)
Figure 1: Epilepsy Prevalence in UK (2012-2018)
Figure 2: UK Epilepsy Market Size (2011-2012)
Figure 3: Epilepsy Products Market Share (%) in UK (2012)
Figure 4: UK Epilepsy Market Forecast (2012-2018)
Figure 5: Epilepsy Products Sales Forecast in UK (2012-2018)
Figure 6: Future Epilepsy Products Market Share (%) in UK (2018)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S